Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
80°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adagio Therapeutics Inc
(NQ:
ADGI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 12, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
4.520 (1)
Ask (Size)
4.760 (2)
Prev. Close
4.640
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
IVVD FINAL DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
March 30, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI
February 07, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
More News
Read More
NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
February 02, 2023
From
Rosen Law Firm
Via
Business Wire
Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy
April 14, 2022
Via
Benzinga
Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop
December 19, 2022
From
Invivyd
Via
GlobeNewswire
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer
December 06, 2022
From
Invivyd
Via
GlobeNewswire
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
August 22, 2022
Via
Benzinga
Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
August 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 19, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 27, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 27, 2022
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 06, 2022
Via
Benzinga
Mithril Capital’s Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy Campaign
July 05, 2022
From
Mithril Capital Management LLC
Via
Business Wire
30 Stocks Moving In Monday's Mid-Day Session
May 23, 2022
Via
Benzinga
58 Biggest Movers From Yesterday
May 24, 2022
Via
Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
March 31, 2022
Via
Benzinga
51 Biggest Movers From Yesterday
March 31, 2022
Via
Benzinga
Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher
March 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 30, 2022
Via
Benzinga
S&P 500 Set to Snap 4-Day Win Streak Despite Jobs Data
March 30, 2022
Via
Talk Markets
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
March 30, 2022
Via
InvestorPlace
MRNA Stock: What’s Going on With Moderna This Week?
March 30, 2022
Via
InvestorPlace
SPCE Stock: What’s Going on With Virgin Galactic This Week?
March 30, 2022
Via
InvestorPlace
Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge
March 30, 2022
Via
Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
March 30, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.